- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Valens Groworks Grants Option to Buy 320,000 Shares
Valens Groworks Corp. (CSNX:VGW) has granted incentive stock options to an incoming consultant of the company’s wholly owned subsidiary, Valens Agritech Ltd., to purchase up to 320,000 common shares of the company at a price of $1.25 per common share.
Valens Groworks Corp. (CSNX:VGW) has granted incentive stock options to an incoming consultant of the company’s wholly owned subsidiary, Valens Agritech Ltd., to purchase up to 320,000 common shares of the company at a price of $1.25 per common share.
The stock purchase options are exercisable on or before Feb. 29, 2020, and vest in stages over the course of three years, with 20,000 options to vest immediately and 20,000 options to vest in each three-month period over three years. The remaining 80,000 options may be vested at the discretion of the board of directors based upon the achievement of specific corporate objectives.
The stock options are being granted pursuant to the terms of the company’s stock option plan and are subject to regulatory approval.
About Valens Groworks Corp.
Valens Groworks is a Canadian Securities Exchange-listed company with two proposed acquisitions in progress, proposes to provide management, consulting, testing and support services to domestic and international licensees, and seeks to capture a broad spectrum of medical marijuana users, as well as recreational users once legalized, in pursuit of its ambitious farm-to-pharma objectives.
The company’s wholly owned subsidiary, Valens Agritech, is a postinspection applicant awaiting the granting of a controlled drugs and substances dealer’s licence for the cultivation and processing of marijuana. Based in the Okanagan Valley of British Columbia, Valens Agritech anticipates participation in clinical trial programs researching the efficacy of medical cannabis.
Click here to connect with Valens Groworks Corp. (CSNX:VGW) to receive an Investor Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.